753 related articles for article (PubMed ID: 23103135)
1. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
[TBL] [Abstract][Full Text] [Related]
2. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population.
Cai A; Li G; Chen J; Li X; Li L; Zhou Y
BMC Cardiovasc Disord; 2015 Feb; 15():14. PubMed ID: 25879827
[TBL] [Abstract][Full Text] [Related]
3. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
[TBL] [Abstract][Full Text] [Related]
4. [Association of lipoprotein-associated phospholipase activity A2 with cardiovascular risk factors].
Acevedo M; Varleta P; Kramer V; Quiroga T; Prieto C; Parada J; Adasme M; Briones L; Navarrete C
Rev Med Chil; 2013 Nov; 141(11):1382-8. PubMed ID: 24718463
[TBL] [Abstract][Full Text] [Related]
5. Higher lipoprotein-associated phospholipase A2 levels are associated with coronary atherosclerosis documented by coronary angiography.
Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Thuboi S; Ogita M; Miyazaki T; Nishino A; Yokoyama K; Kurata T; Yatomi Y; Daida H
Ann Clin Biochem; 2012 Nov; 49(Pt 6):527-33. PubMed ID: 22933444
[TBL] [Abstract][Full Text] [Related]
6. Association of Lp-PLA2 with digital reactive hyperemia, coronary flow reserve, carotid atherosclerosis and arterial stiffness in coronary artery disease.
Ikonomidis I; Kadoglou NN; Tritakis V; Paraskevaidis I; Dimas K; Trivilou P; Papadakis I; Tzortzis S; Triantafyllidi H; Parissis J; Anastasiou-Nana M; Lekakis J
Atherosclerosis; 2014 May; 234(1):34-41. PubMed ID: 24594367
[TBL] [Abstract][Full Text] [Related]
7. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
[TBL] [Abstract][Full Text] [Related]
8. [The correlation of human serum Lp-PLA2 and hs-CRP and stability of coronary atherosclerotic plaques].
Xu DL; Liu JN; Du YM; Yao GH; Jiang WD; Wang X; Dong ZQ; Hao L; Wang GY; Sui SJ; Li JF; Lu QH
Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):651-4. PubMed ID: 19954057
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
[TBL] [Abstract][Full Text] [Related]
10. Plasma lipoprotein-associated phospholipase A2 mass is elevated in STEMI compared to non-STEMI patients but does not discriminate between myocardial infarction and non-cardiac chest pain.
Dullaart RP; van Pelt LJ; Kwakernaak AJ; Dikkeschei BD; van der Horst IC; Tio RA
Clin Chim Acta; 2013 Sep; 424():136-40. PubMed ID: 23756128
[TBL] [Abstract][Full Text] [Related]
11. Phospholipase A2 in patients with noncardioembolic ischemic stroke and severe inflammatory reaction.
Cojocaru IM; Cojocaru M; Tănăsescu R; Iliescu I; Dumitrescu L; Burcin C; Gurban CV; Sfrijan F
Rom J Intern Med; 2009; 47(1):61-5. PubMed ID: 19886071
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Chambless LE; Myerson M; Wu KK; Sharrett AR; Boerwinkle E
Arch Intern Med; 2005 Nov; 165(21):2479-84. PubMed ID: 16314544
[TBL] [Abstract][Full Text] [Related]
13. Utility of lipoprotein-associated phospholipase A2 for prediction of 30-day major adverse coronary event in patients with the first anterior ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
Stankovic S; Asanin M; Trifunovic D; Majkic-Singh N; Miljković A; Ignjatovic S; Mrdovic I; Matic D; Savic L; Ostojic M; Vasiljevic Z
Clin Lab; 2012; 58(11-12):1135-44. PubMed ID: 23289182
[TBL] [Abstract][Full Text] [Related]
14. Utility of Lp-PLA2 in lipid-lowering therapy.
Racherla S; Arora R
Am J Ther; 2012 Mar; 19(2):115-20. PubMed ID: 20634673
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease.
Mourouzis K; Siasos G; Oikonomou E; Zaromitidou M; Tsigkou V; Antonopoulos A; Bletsa E; Stampouloglou P; Vlasis K; Vavuranakis M; Tousoulis D
Lipids Health Dis; 2021 Feb; 20(1):12. PubMed ID: 33583415
[TBL] [Abstract][Full Text] [Related]
16. Plasma Lp-PLA2 in acute coronary syndrome: association with major adverse cardiac events in a community-based cohort.
Li N; Li S; Yu C; Gu S
Postgrad Med; 2010 Jul; 122(4):200-5. PubMed ID: 20675983
[TBL] [Abstract][Full Text] [Related]
17. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
[TBL] [Abstract][Full Text] [Related]
18. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans.
Lavi S; McConnell JP; Rihal CS; Prasad A; Mathew V; Lerman LO; Lerman A
Circulation; 2007 May; 115(21):2715-21. PubMed ID: 17502572
[TBL] [Abstract][Full Text] [Related]
19. Circulating lipoprotein-associated phospholipase A2 in high-grade carotid stenosis: a new biomarker for predicting unstable plaque.
Sarlon-Bartoli G; Boudes A; Buffat C; Bartoli MA; Piercecchi-Marti MD; Sarlon E; Arnaud L; Bennis Y; Thevenin B; Squarcioni C; Nicoli F; Dignat-George F; Sabatier F; Magnan PE;
Eur J Vasc Endovasc Surg; 2012 Feb; 43(2):154-9. PubMed ID: 22075154
[TBL] [Abstract][Full Text] [Related]
20. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
